| 26.24 Data as of 3:59pm ET | +0.10 / +0.38%Today’s Change | 21.21 Today|||52-Week Range 28.11 | +3.59% Year-to-Date |
The investment seeks investment results that, before fees and expenses, correspond generally to the total return performance of an index. The fund employs a sampling strategy in seeking to track the performance of the S&P Developed Ex-U.S. BMI Index. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index or in ADRs or GDRs based on securities comprising the index. The index is a market capitalization weighted index designed to define and measure the investable universe of publicly traded companies domiciled in developed countries outside the United States. The fund is non-diversified.
| 1 month | -3.56% | 3 years | +10.29% | |
| 3 months | +0.64% | 5 years | -1.36% | |
| 1 year | +27.95% | Since inception | -1.21% |
| Previous close | $26.14 |
| Open day’s range | 26.00 – 26.27 |
| Net asset value (NAV) | 26.19 (06/05/2013) |
| Daily volume | 57,372 |
| Average volume (3 months) | 109,747 |
| GWL | Category | |
|---|---|---|
| Performance 5-yr return | -1.36% | -0.28% |
| Expense Gross exp ratio | 0.34% | 0.43% |
| Risk 5 year sharpe ratio | 0.05 | 0.07 |
| Net assets | $605.8M | $3.5B |
| Average market cap | $22.2B | $35.1B |
| Average P/E | 14.9 | 13.9 |
| Dividend / Share | -- | 0.47% |
| EFA iShares MSCI EAFE Index Fund |
| SCHF Schwab International Equity ETF |
| VEA Vanguard FTSE Developed Markets ETF |
| Industrial materials | 22.66% |
| Financial service | 21.97% |
| Consumer goods | 13.88% |
| Energy | 9.30% |
| Healthcare | 7.88% |
| -- Nestle SA | 1.50% |
| -- Samsung Electrs 144A | 1.30% |
| -- HSBC Holdings PLC | 1.28% |
| -- Roche Holding AG | 1.23% |
| -- Novartis AG | 1.22% |
| -- Toyota Motor Corp | 1.09% |
| -- Vodafone Group PLC | 0.95% |
| -- BP PLC | 0.94% |
| -- Royal Dutch Shell PLC Class A | 0.83% |
| -- GlaxoSmithKline PLC | 0.82% |